Table II.
Characterizing fellows in training who were reassigned to COVID-19 responsibilities and a comparison with those not reassigned
| Fellows-in-training reassigned (n = 15) | Fellows-in-training not reassigned (n = 109) | P value | |
|---|---|---|---|
| Reassignment setting∗, n (%) | |||
| Emergency medicine | 3 (20) | ||
| Adult inpatient medicine | 10 (66.7) | ||
| Other† | 3 (20) | ||
| Reassignment characteristics, n (%) | |||
| Voluntary reassignment | 3 (20.0) | ||
| Directly managed patients with COVID-19 during reassignment | 14 (93.3) | ||
| Board certification, n (%) | .09 | ||
| Internal Medicine | 11 (73.3) | 44 (40.7) | |
| Pediatrics | 3 (20.0) | 53 (49.1) | |
| Internal Medicine and Pediatrics | 0 | 6 (5.6) | |
| Neither Internal Medicine nor Pediatrics | 1 (6.7) | 5 (4.6) | |
| Anticipated graduation year, n (%) | |||
| Graduating in 2020 | 5 (33.3) | 56 (51.4) | |
| Graduating in 2021 or 2022 | 10 (66.7) | 53 (48.6) | |
| Unrestricted full medical license, n (%) | 9 (60.0) | 94 (87.0) | .01 |
| Prior attending level experience, n (%) | 5 (33.3) | 34 (31.5) | >.99 |
| Underlying medical conditions perceived as COVID-19 risk factors, n (%) | 2 (13.3) | 26 (24.8) | .51 |
| Concerned about lacking skills to practice Allergy Immunology independently after graduation, n (%) | 6 (40.0) | 19 (18.1) | .08 |
| Concerned about inability to complete research project before graduation, n (%) | 7 (46.7) | 39 (37.1) | .57 |
COVID-19, Coronavirus disease 2019; FIT, fellow-in-training.
∗
One FIT was reassigned to more than 1 location.
†
Other locations included televisits, outpatient drive through testing, and a decision support unit for patients with COVID-19 illness.